Home » Newsletters » BioWorld Science

BioWorld Science

July 18, 2011

View Archived Issues

New modulators of metabotropic glutamate mGlu5 receptor presented

Pilot study provides proof of principle for ALX-0081 in percutaneous coronary intervention

Phase II data support use of ThromboView in SPECT for diagnosis of acute pulmonary embolism

Hydrogen sulfide donor GYY-4137 exhibits potent preclinical antitumor activity

Ajinomoto set for Japanese launch of Azuloxa tablets for gastric ulcers

Researchers describe pharmacological profile of AM-211

Novel integrin alpha-V/beta-6 ligands patented by GE Healthcare

New diagnostic glutamate carboxypeptidase 2 inhibitors synthesized

InterMune presents new HCV replication inhibitors

Novo Nordisk discloses novel glucagon GLP-1 receptor agonists

New gap junction hemichannel blocker prevents disease progression in murine models of ALS and AD

New PI3K-delta inhibitors prepared by Incyte

Nycomed patents new inhibitors of phosphodiesterase 4B and/or phosphodiesterase 5A

BioFocus and Michael J. Fox Foundation collaborate for Parkinson's disease

BerGenBio prepares for clinical studies of lead oncology candidate BGB-324

Laboratoires Takeda withdraws pioglitazone-containing products from French market

FDA approves highest dose strength of Zenpep to date

Leo Pharma and The Scripps Research Institute enter collaboration for treatment of skin diseases

Topline phase III data reported on fixed-dose levomilnacipran in MDD

Almirall launches Sativex in Denmark for spasticity due to MS

NeoStem signs definitive merger agreement to acquire Amorcyte

Amgen gains European marketing approval for Xgeva

QrxPharma files MoxDuo NDA in U.S. for severe pain

FDA accepts for review MedImmune's sBLA for quadrivalent influenza vaccine Q/LAIV

Cell Biosciences becomes ProteinSimple

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...